Most Recent Additions*
1709P Outcomes with novel combinations in non-clear cell renal cell carcinoma (nccRCC): ORACLE study
D. Kilari, A. Szabo, M. A. Bilen, Y. Ged, B. L. Maughan, Clara Hwang, H. McManus, P. M. Coelho Barata, A. Desai, Y. Zakharia, H. Emamekhoo, A. Tripathi, T. Rose, P. Ghatalia, M. A. Reimers, E. Heath, J. M. King, B. I. Rini, J. Brugarolas, and R. R. McKay
Outcomes of Acute Myeloid Leukemia Treated with a Hypomethylating Agent and Venetoclax: A Single Institution Analysis
Markie Zimmer, Brigid Jacob, Mikayla Spica, Sunita Ghosh, and Vrushali S. Dabak
DRAGON TRIAL: DURABLE REMISSION RATE WITH THE LATENT TGFb1 INHIBITOR LINAVONKIBART (SRK-181) AND PEMBROLIZUMAB IN PATIENTS WITH IMMUNE CHECKPOINT INHIBITOR RESISTANT ADVANCED CANCERS
Timothy A. Yap, Randy Sweis, Ulka N. Vaishampayan, Deepak Kilari, Ahmad A. Tarhini, Justin F. Gainor, Minal Barve, Guru P. Sonpavde, David Park, Sunil Babu, Rana McKay, Clara Hwang, Amna Sher, Chaitali Nangia, Miso Kim, Jungyoon Choi, Yawen Ju, Lan Liu, Susan Henry, Stephen DeWall, and Lu Gan
Real World Data on the Utility of P-Selectin Expression Assay; Correlation of Test Results and Disease Expression
Aroob Sweidan, Rachel L. Brancamp, Ileana Lopez-Plaza, Gordon Jacobsen, and Philip Kuriakose
Second Infusion of CAR T-Cells in Patients with Relapsed /Refractory B-Cell Acute Lymphoblastic Leukemia: Results from a Gocart Coalition Analysis on Behalf of the PDWP, ALWP, and Ctiwp of the EBMT
Susana Rives, Giorgio Ottaviano, Nuria Martínez-Cibrián, Shatha Y. Farhan, Sowjanya Vuyyala, Jacques-Emmanuel Galimard, Eva Michel, Fizza Imran, Nazaret Sánchez-Sierra, Richard Mitchell, Stephan Mielke, Andishe Attarbaschi, Soeren Lykke Petersen, Ryhanen Samppa Sr., Wolfgang A. Bethge, David Beauvais, Tsila Zuckerman, Antonio Pérez-Martínez, Krzysztof Kalwak, Fabio Ciceri, Annalisa Ruggeri, Julio Delgado, Sebastian Giebel, Adriana Balduzzi, Anna Alonso-Saladrigues, and Valentin Ortiz-Maldonado
Unfractionated Heparin Vs Enoxaparin Thromboprophylaxis in Medical-Surgical Patients: A Systematic Review and Meta-Analysis
Aakanksha Pitliya, Srivatsa S. Vasudevan, Vanshika Batra, Vishal Karmani, Anand Shah, Dhairya Gor, and Anmol Pitliya
The Mediating Effects of Racial and Social Health Disparities on Cancer Urgent Care Outcomes: An Urban Cancer Center Experience
Matthew Meranda, Madison Drallmeier, Sisira Kavuri, Jamie Abad, Aayush Mittal, Rida Farook, Muniza Hossain, Courtney Rose, Carl P. Wilson, Muhammad Shahid, Philip Kuriakose, and Ahmad H. Mattour
SPATIAL LOCALIZATION OF MACROPHAGES AND CANCER-ASSOCIATED FIBROBLASTS IN PANCREATIC CANCER: IMPLICATIONS FOR MYELOID TARGETING STRATEGIES
Natalie K. Horvat, Emily Greene, Alyssa Krasinskas, Maria Diab, Shishir Maithel, Juan Sarmiento, Olatunji Alese, and Gregory B. Lesinski
Initial Results from the BEACON Clinical Study: A Phase 1/2 Study Evaluating the Safety and Efficacy of a Single Dose of Autologous CD34+ Base Edited Hematopoietic Stem Cells (BEAM-101) in Patients with Sickle Cell Disease with Severe Vaso-Occlusive Crises
Ashish O. Gupta, Akshay Sharma, Haydar Frangoul, Jignesh Dalal, Julie Kanter, Asif Alavi, John DiPersio, Mary Eapen, Jennifer J. Jaroscak, Ernesto Ayala, Edward D. Ziga, Stacey Rifkin-Zenenberg, Alex C. Minella, Guo Chen, Yinzhong Chen, Priya S. Chockalingam, Ling Lin, Marcelyne Joseney-Antoine, Leanne Ianniello, Beth Gardner, Adam J. Hartigan, Giuseppe Ciaramella, Sunita Goyal, Amy Simon, Alexis Thompson, and Matthew M. Heeney
Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of KT-333, a Targeted Protein Degrader of STAT3, in Patients with Relapsed or Refractory Lymphomas, Leukemia, and Solid Tumors
Tatyana Feldman, Enrica Marchi, Stephen D. Smith, Adam J. Olszewski, Auris O. Huen, Zachary D. Epstein-Peterson, Don A. Stevens, Alexander N. Starodub, Eric J. Feldman, Cristina P. Rodriguez, John C. Reneau, Jonathan E. Brammer, Ahmad H. Mattour, Lauren C. Pinter-Brown, Rachelle Perea, Patrick Henrick, Joyoti Dey, Alyssa Fasciano, Rahul Karnik, Sagar Agarwal, and Stefan K. Barta
Quantifying Tertiary Lymphoid Structures in Resected Pancreatic Ductal Adenocarcinoma in Clinical Practice - A Feasibility Study Demonstrating a Correlation with Survival
Brian K. Theisen, Madison George, Ian Loveless, and Nina Steele
Lysine Demethylase 5a (Kdm5a) regulates metabolic activity and tumorigenic potential of murine pancreatic cancer cells
Nicole Schreiner, Lisa Fahr, Simone Benitz, Quan Zhou, Ahmed Alnatsha, Axel Imhof, Ujjwal Mahajan, Julia Mayerle, Gunnar Schotta, and Ivonne Regel
Irf3 and Irf7 induce epigenetic changes to promote pancreatic carcinogenesis
Lisa Fahr, Simone Benitz, Nicole Schreiner, Tobias Straub, Jurik Mutter, Hannah Hamidach, Ujjwal M. Mahajan, Georg Beyer, Katja Steiger, Andrea Terrasi, Gunnar Schotta, Axel Imhof, Kirsten Lauber, Jörg Kleeff, Christoph W. Michalski, Julia Mayerle, and Ivonne Regel
STREAMLINING THE STUDY INTAKE PROCESS AT THE CANCER CLINICAL AND TRANSLATIONAL RESEARCH OFFICE (CCTRO)
Raid Faddah, Tobias Walbert, James Snyder, Shirish Gadgeel, Philip A. Philip, and Lisa M. Lange
Tarlatamab for patients with small cell lung cancer: 6-8 hour outpatient vs 48 hour inpatient monitoring in cycle 1
A. C. Chiang, M. E. Olmedo Garcia, J. Carlisle, A. Dowlati, N. Reguart, E. Felip, P. J. Jost, N. Steeghs, R. Stec, Shirish Gadgeel, H. H. F Loong, W. Jiang, A. Hamidi, A. Parkes, and L. Paz-Ares
OA11.04 Volrustomig + platinum doublet chemotherapy (CTx) in first-line non-small cell lung cancer (NSCLC): Phase 1b trial update
D. R. Spigel, M.-J. Ahn, M. Majem, L. Medina Rodríguez, K. H. Lee, E. Carcereny, A. A. Hernández, A. Insa, E. K. Cho, B. Besse, S. Y. Rha, J. Weiss, M. D'Arcangelo, S.-A. Im, S.-W. Kim, B. A. Carneiro, Shirish M. Gadgeel, P. Mitchell, J. M. Asare, S. D. Gainer, I. Achour, D. S. Subramaniam, and E. Felip
P3.12D.11 Phase 1/2, Dose-expansion Study of AMG 193, an MTA-cooperative PRMT5 Inhibitor, In MTAP-deleted NSCLC
A. Sacher, A. Addeo, T. Doi, Q. Chu, A. El Helali, L. Villaruz, H. Prenen, N. Vokes, J. Rodon, G. Durm, L. Lebellec, B. O’Neil, G. Dy, T. Eggert, K. Keyvanjah, and Shirish Gadgeel
P3.06D.12 Racial Differences in ALK Gene Alterations Detected by Tissue and Liquid Biopsy Across Patients with Lung Cancer
Bindu Potugari, Fawzi Abu Rous, Radhika Gutta, E. Teslow, C. Chao, E. Jaeger, and Shirish Gadgeel
P1.13A.13 ALISertib in Patients with Extensive-Stage Small-Cell Lung Cancer: The Phase 2 ALISCA-Lung1 Study
T. Owonikoko, T. F. Burns, A. A. Chiappori, B. Drapkin, R. D. Gentzler, J. Goldschmidt, D. Hakimian, R. Jotte, S. V. Liu, A. A. Onitilo, N. A. Pennell, Bindu Potugari, J. Rios, J. Sands, A. Spira, B. Wang, D. M. Waterhouse, B. Lowenthal, J. Bebchuk, L. D. Eli, E. K. Wong, and A. Dowlati
The Selective Personalized Radioimmunotherapy for Locally Advanced NSCLC Trial (SPRINT): Patient-Reported Outcomes
N. Ohri, S. Jolly, B. Cooper, R. Kabarriti, W. R. Bodner III, C. Guha, S. Viswanathan, E. Shum, J. K. Sabari, H. Cheng, R. Gucalp, E. Castellucci, A. Qin, Shirish M. Gadgeel, and B. Halmos
*Updated as of 03/25/25.
